(Q34518299)

2 August 2017

title

Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis (English)

1 reference

2 August 2017

0 references

anti-retroviral agent

0 references

author name string

T Wolf

1

1 reference

2 August 2017

B Fuß

2

1 reference

2 August 2017

P Khaykin

3

1 reference

2 August 2017

A Berger

4

1 reference

2 August 2017

G Knecht

5

1 reference

2 August 2017

P Gute

6

1 reference

2 August 2017

H R Brodt

7

1 reference

2 August 2017

S Goepel

8

1 reference

2 August 2017

M Bickel

9

1 reference

2 August 2017

M Stuermer

10

1 reference

2 August 2017

C Stephan

11

1 reference

2 August 2017

Frankfurt HIV Cohort Study

12

1 reference

2 August 2017

publication date

23 August 2014

1 reference

Medical Microbiology and Immunology

2 August 2017

published in

1 reference

2 August 2017

volume

203

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

409-414

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-014-0350-5

2 August 2017

exact match

0 references

cites work

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233158

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233158

Maraviroc for previously treated patients with R5 HIV-1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233158

Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233158

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4233158

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial

7 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Modifications and substitutions of the RNA extraction module in the ViroSeq HIV-1 genotyping system version 2: effects on sensitivity and complexity of the assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0350-5

Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25148909

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00430-014-0350-5

1 reference

Dimensions Publication ID

2 August 2017

1018893987

0 references

Fatcat ID

release_wjmuavz3i5e5hdapfkue5kzf5a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wjmuavz3i5e5hdapfkue5kzf5a

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

4233158

1 reference

2 August 2017

1 reference